PNC Financial Services Group
PMVP icon

PNC Financial Services Group’s PMV Pharmaceuticals PMVP Stock Holding History

PNC Financial Services Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.7K Sell
68,292
-4,919
-7% -$6.26K ﹤0.01% 2926
2025
Q4 		$91.5K Buy
73,211
+2,205
+3% +$2.95K ﹤0.01% 2853
2025
Q3 		$99.4K Buy
71,006
+10,186
+17% +$14.1K ﹤0.01% 2811
2025
Q2 		$64.5K Sell
60,820
-1,314
-2% -$1.29K ﹤0.01% 2972
2025
Q1 		$67.7K Sell
62,134
-6,979
-10% -$9.47K ﹤0.01% 2917
2024
Q4 		$104K Sell
69,113
-116
-0.2% -$184 ﹤0.01% 2651
2024
Q3 		$103K Buy
69,229
+25,983
+60% +$40.1K ﹤0.01% 2654
2024
Q2 		$70.1K Buy
43,246
+43,220
+166,231% +$77.9K ﹤0.01% 2848
2024
Q1 		$44 Hold
26
– – ﹤0.01% 4668
2023
Q4 		$81 Sell
26
-961
-97% -$2.54K ﹤0.01% 4530
2023
Q3 		$6.06K Hold
987
– – ﹤0.01% 3936
2023
Q2 		$6.18K Hold
987
– – ﹤0.01% 4053
2023
Q1 		$4.71K Buy
+987
New +$6.95K ﹤0.01% 4058

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PNC Financial Services Group's PMVP Position: Q1 2026 in Review

PNC Financial Services Group reduced its PMV Pharmaceuticals (PMVP) stake by 6.7% in Q1 2026, selling an estimated $6.26K and leaving 68,292 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

PNC Financial Services Group first reported a position in PMVP in Q1 2023 and has held it in 13 quarters since. The position peaked at $104K in Q4 2024. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • PNC Financial Services Group held 68,292 shares of PMV Pharmaceuticals worth $84.7K as of Q1 2026.
  • PNC Financial Services Group sold 4,919 PMV Pharmaceuticals shares in Q1 2026, an estimated $6.26K.
  • PMV Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2926 holding.
  • PNC Financial Services Group first reported a position in PMV Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • PNC Financial Services Group's PMV Pharmaceuticals position peaked at $104K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.